Search Results - "Wong, Frankie A"

Levofloxacin Population Pharmacokinetics and Creation of a Demographic Model for Prediction of Individual Drug Clearance in Patients with Serious Community-Acquired Infection by PRESTON, S. L, DRUSANO, G. L, BERMAN, A. L, FOWLER, C. L, CHOW, A. T, DORNSEIF, B, REICHL, V, NATARAJAN, J, WONG, F. A, CORRADO, M

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Pharmacokinetic overview of Ortho Evra/Evra by Abrams, Larry S, Skee, Donna, Natarajan, Jaya, Wong, Frankie A

“…The pharmacokinetics of norelgestromin, the primary active metabolite of norgestimate, plus ethinyl estradiol (EE), delivered by the once-weekly contraceptive…”
Get more information

Pharmacokinetics of a contraceptive patch (Evra™/Ortho Evra™) containing norelgestromin and ethinyloestradiol at four application sites by Abrams, Larry S., Skee, Donna M., Natarajan, Jaya, Wong, Frankie A., Anderson, Gary D.

“…Aims  To determine the pharmacokinetic profile of norelgestromin (NGMN) and ethinyloestradiol (EE) following application of the contraceptive patch, Evra™/…”
Get full text

Pharmacokinetics of Norelgestromin and Ethinyl Estradiol Delivered by a Contraceptive Patch (Ortho Evra™/Evra™) under Conditions of Heat, Humidity, and Exercise by Abrams, Larry S., Skee, Ms. Donna M., Natarajan, Jaya, Wong, Frankie A., Leese, Philip T., Creasy, George W., Shangold, Mona M.

“…The objectives of this randomized, open‐label, three‐period, incomplete block design study were to evaluate the pharmacokinetics of norelgestromin (NGMN) and…”
Get full text

Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants by Abrams, Larry S., Skee, Donna M., Natarajan, Jaya, Wong, Frankie A., Lasseter, Kenneth C.

“…This open-label, randomized study evaluated the pharmacokinetics of norelgestromin (NGMN) and ethinyl estradiol (EE) following the application of a…”
Get full text

Pharmacokinetics of Norelgestromin and Ethinyl Estradiol from Two Consecutive Contraceptive Patches by Abrams, Larry S., Skee, Ms. Donna M., Wong, Frankie A., Anderson, Ms. Nika J., Leese, Philip T.

“…The primary objective of this open‐label study was to determine the pharmacokinetics of norelgestromin (NGMN) and ethinyl estradiol (EE) following two…”
Get full text

Pharmacokinetics of Norelgestromin and Ethinyl Estradiol from Two Consecutive Contraceptive Patches by Abrams, Larry S, Skee, Donna M, Wong, Frankie A, Anderson, Nika J, Leese, Philip T

“…The primary objective of this open-label study was to determine the pharmacokinetics of norelgestromin (NGMN) and ethinyl estradiol (EE) following two…”
Get full text

Pharmacokinetics of Norelgestromin and Ethinyl Estradiol Delivered by a Contraceptive Patch (Ortho Evra+/Evra+) under Conditions of Heat, Humidity, and Exercise by Abrams, Larry S, Skee, Donna M, Natarajan, Jaya, Wong, Frankie A, Leese, Philip T, Creasy, George W, Shangold, Mona M

“…The objectives of this randomized, open-label, three-period, incomplete block design study were to evaluate the pharmacokinetics of norelgestromin (NGMN) and…”
Get full text

Bioequivalence of a newly developed 17β-estradiol tablet versus an identical reference formulation by GISCLON, Lee G, BOWEN, Angela J, O'REILLY, Terry E, LAKEWOLD, Dorothy, CURTIN, Christopher R, LARSON, Kathy L, PALMER, Sally A, NATARAJAN, Jaya, WONG, Frankie A

“…Two open-label, randomized studies determined the bioequivalence of a test preparation (Prefest) of micronized 17 beta-estradiol (E2, CAS 50-28-2) tablets as…”
Get full text